CN1269520C - Medicine for treating human lithic disease - Google Patents

Medicine for treating human lithic disease Download PDF

Info

Publication number
CN1269520C
CN1269520C CNB031267971A CN03126797A CN1269520C CN 1269520 C CN1269520 C CN 1269520C CN B031267971 A CNB031267971 A CN B031267971A CN 03126797 A CN03126797 A CN 03126797A CN 1269520 C CN1269520 C CN 1269520C
Authority
CN
China
Prior art keywords
medicine
radix
rhizoma
lithiasis
calculi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB031267971A
Other languages
Chinese (zh)
Other versions
CN1552386A (en
Inventor
黄山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB031267971A priority Critical patent/CN1269520C/en
Publication of CN1552386A publication Critical patent/CN1552386A/en
Application granted granted Critical
Publication of CN1269520C publication Critical patent/CN1269520C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a medicine for treating human lithiasis, and raw material components comprise yellow croaker ear-stone, chuanposhi, talcum, mirabilite, giant knotweed rhizome, longhairy antenoron herb, rhubarb, virgate wormwood herb, golden thread, amur cork-tree, Japanese climbing fern spore, curcuma aromatica, rhizome coridalis, fructus aurantii, areca seed, chicken's gizzard-membrane, Chinese yhorowax root, radix aucklandiae and rhizoma cyperi. The present invention has the functions of relieving inflammation and pain, alleviating depression to regulate Qi, dispersing stagnated liver Qi, activating blood circulation to dissipate blood stasis, softening hard masses, breaking accumulation, washing six fu organs and repelling aetiological agent, the effect of the medicine taken by a patient can gradually permeate in calculi so as to expand, soften and dissolve the calculi, and the calculi in different ill positions can be easily discharged out of a human body without blood or pain under the action of the medicine on promoting the gall bladder and promoting urination. The present invention has universality and can be used for treating different lithiasis, the patient needs to take little medicine in the whole process, the medicine taking dosage is only from 3 to 20 preparations according to the degree of diseases, and the safe and economic medicine for treating human lithiasis has more than recovery rate of 95%.

Description

A kind of medicine for the treatment of the calculosis disease
Technical field
This utility model relates to the Chinese patent medicine of the treatment calculosis disease that a kind of traditional traditional Chinese medical science uses, be meant especially a kind of to each position, various calculosis all have curative effect, lithodialysis, fossil, painless urinary calculus removing Chinese patent medicine.
Background technology
Calculus is a kind of multiple disease, mainly by environmental pollution, psychentonia, eating and drinking without temperance, drinking-water less at ordinary times, physical function is impaired etc., and the unusual condensing crystallizing oxidation of body fluid is formed.Theory of Chinese medical science think calculus all by the foul stasis of blood stagnate, FU QI being obstructed, damp and hot continuing do and be trouble, its formation be one by liquid state to solid-state process.Clinically, calculus is commonly encountered diseases, frequently-occurring disease, and present Therapeutic Method and prescription do not have big breakthrough.Three kinds of methods of now many employings: the first takes operation method to take out calculus, and this therapy has certain risk, and the wound that patient suffers is big, and medical expense is comparatively expensive; It two is to take the ultrasound wave lithotripsy in treatment, and this method patient suffers wound little, but not good enough for calculus patient effect really up to the mark, even can not cure by ultrasound wave rubble method, and the medical expense height; It three is to adopt Drug therapy, wherein adopt Western medicine still not have specific medicament, general just reducing swelling and alleviating pain is difficult to stone is discharged, for Western medicine, many Chinese medicines have then been obtained good curative effect, as widely used lithagogue infusion, XIAOYAN LIDAN PIAN, AIHUO DANTONG etc. clinically, but said medicine is only effective in cure to less calculus, and calculus is surpassed one centimetre of special calculus unsatisfactory curative effect of person or position, even can not get rid of, also exist medicine time long, side effect big, calculus process misery etc.Preceding two kinds are physiotherapy, all have certain danger and nocuity, and easy infection, easily residual, easy recurrence, real method for only curing the symptoms, not the disease.
Summary of the invention
The purpose of this invention is to provide and a kind ofly can effectively dissolve calculus and with its effective discharge in the person, and to the Chinese patent medicine of calculus position, kind wide adaptability.
Designed a kind of medicine for the treatment of the calculosis disease according to above-mentioned purpose, the raw material components of this medicine comprises Asteriscus Pseudosciaenae, Radix Cudraniae, Talcum, Natrii Sulfas, Rhizoma Polygoni Cuspidati, Herba Lysimachiae, Radix Et Rhizoma Rhei, Herba Artemisiae Scopariae, Rhizoma Coptidis, Cortex Phellodendri, Spora Lygodii, Radix Curcumae, Rhizoma Corydalis, Fructus Aurantii, Semen Arecae, Endothelium Corneum Gigeriae Galli, Radix Bupleuri, the Radix Aucklandiae, Rhizoma Cyperi.
The percentage by weight of this each raw material of medicine is:
Asteriscus Pseudosciaenae 8~15% Radix Cudraniaes 10~15% Talcums 2~5%
Natrii Sulfas 2~5% Rhizoma Polygoni Cuspidati 3~8% Herba Lysimachiaes 7~15%
Radix Et Rhizoma Rhei 2~5% Herba Artemisiae Scopariaes 2~5% Spora Lygodii 7~15%
Radix Curcumae 5~10% Rhizoma Corydalis 3~7% Fructus Aurantiis 2~5%
Semen Arecae 5~10% Endothelium Corneum Gigeriae Galli 6~12% Radix Bupleuri 3.5~8%
The Radix Aucklandiae 1~3% Rhizoma Cyperi 1~5%
Add man-hour, can make liquor, after sterilize, pack decocting after the medicament mixed in the said components; Or,, be mixed into powder after the pulverizing or make pill by the filling machine dress more respectively through processed with salt or vinegar system with the clean back of the classification of drug in described component sterilization treatment.
The present invention by anti-inflammatory analgetic, the chest stuffiness relieving regulate the flow of vital energy, dispersing the stagnated live-QI to relieve the stagnation of QI, blood circulation promoting and blood stasis dispelling, softening the hard mass removing mass, wash six internal organs, by the cause of disease, the medicine efficacy of a drug can penetrate into calculus inside gradually after the patient took medicine, make the dissolving of calculus expansion pineization, and by the effect of function of gallbladder promoting diuretic, depletion of blood is painless, easily the calculus with different sick positions excretes.Whole process patient's dosage is little, according to only 3~20 doses of the weight dosages of disease, and safety economy, cure rate is more than 95%.
Specific embodiments
The present invention can adjust the dosage form of taking medicine, dosage according to patient's concrete disease and physical condition, and the molding medicament can be serial Chinese patent medicines such as powder, electuary, pill, tablet, capsule or even water preparation.
Embodiment 1, take by weighing herbal raw material (kilogram) by following weight proportion:
Asteriscus Pseudosciaenae 15 Radix Cudraniaes 10 Talcums 5 Natrii Sulfas 2 Rhizoma Polygoni Cuspidati 5
Herba Lysimachiae 10 Radix Et Rhizoma Rhei 3 Herba Artemisiae Scopariaes 5 Spora Lygodii 10
Radix Curcumae 5 Rhizoma Corydalis 3 Fructus Aurantiis 2 Semen Arecaes 5 Endothelium Corneum Gigeriae Galli 8
Radix Bupleuri 4 Radix Aucklandiae 3 Rhizoma Cyperis 5
Above-mentioned raw materials difference drying, pulverizing back are mixed, decoct and make liquor, after sterilize, pack, standby; Or,, be mixed into powder after the pulverizing or make pill by the filling machine dress more respectively through processed with salt or vinegar system with the clean back of the classification of drug in described component sterilization treatment.
Embodiment 2, take by weighing herbal raw material (kilogram) by following weight proportion:
Asteriscus Pseudosciaenae 8 Radix Cudraniaes 7 Talcums 2 Natrii Sulfas 4 Rhizoma Polygoni Cuspidati 6
Herba Lysimachiae 15 Radix Et Rhizoma Rhei 2 Herba Artemisiae Scopariaes 3 Spora Lygodii 10
Radix Curcumae 8 Rhizoma Corydalis 3 Fructus Aurantiis 2 Semen Arecaes 7 Endothelium Corneum Gigeriae Galli 6
Radix Bupleuri 5 Radix Aucklandiae 5 Rhizoma Cyperis 7
Processing method is the same.
The present invention controls by comprehensively distinguishing, has taked depressed liver-energy dispersing and function of gallbladder promoting, kidney tonifying diuresis, heat-clearing and toxic substances removing, lithodialysis softening the hard mass removing mass method, and it is remarkable to be used for clinical efficacy, and the efficacy of a drug can penetrate into calculus inside gradually after the medication, makes calculus expansion pineization, dissolving and discharge.Clinical observation hundred routine patients take the curative effect situation and add up as follows:
Follow up a case by regular visits to Number Treated 3~15 days Effective percentage %
Take a turn for the better 6 6
Produce effects 8 8
Cure 84 84
Invalid 2
Add up to 100 98
Annotate: cause of invalidity 1, gallbladder necrosis, organic damage has lost the healing condition;
2, sb.'s sickness becomes critical, and serious the obstruction changes the treatment that operates on.

Claims (2)

1, a kind of medicine for the treatment of the calculosis disease is characterized in that the raw material components of this medicine is
Asteriscus Pseudosciaenae, Radix Cudraniae, Talcum, Natrii Sulfas, Rhizoma Polygoni Cuspidati, Herba Lysimachiae, Radix Et Rhizoma Rhei, Herba Artemisiae Scopariae, Rhizoma Coptidis, Cortex Phellodendri, Spora Lygodii, Radix Curcumae, Rhizoma Corydalis, Fructus Aurantii, Semen Arecae, Endothelium Corneum Gigeriae Galli, Radix Bupleuri, the Radix Aucklandiae, Rhizoma Cyperi,
The percentage by weight of this each raw material of medicine is
Asteriscus Pseudosciaenae 8~15% Radix Cudraniaes 10~15% Talcums 2~5%
Natrii Sulfas 2~5% Rhizoma Polygoni Cuspidati 5~8% Herba Lysimachiaes 7~15%
Radix Et Rhizoma Rhei 3~7% Herba Artemisiae Scopariaes 2~5% Spora Lygodii 7~15%
Radix Curcumae 5~10% Rhizoma Corydalis 3~7% Fructus Aurantiis 2~5%
Semen Arecae 5~10% Endothelium Corneum Gigeriae Galli 6~12% Radix Bupleuri 3.5~8%
The Radix Aucklandiae 3~6% Rhizoma Cyperis 5~8%.
2, the preparation method of medicine according to claim 1 is characterized in that making liquor with decocting after the medicament mixed in the described component, after sterilize, pack.
CNB031267971A 2003-06-05 2003-06-05 Medicine for treating human lithic disease Expired - Fee Related CN1269520C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB031267971A CN1269520C (en) 2003-06-05 2003-06-05 Medicine for treating human lithic disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB031267971A CN1269520C (en) 2003-06-05 2003-06-05 Medicine for treating human lithic disease

Publications (2)

Publication Number Publication Date
CN1552386A CN1552386A (en) 2004-12-08
CN1269520C true CN1269520C (en) 2006-08-16

Family

ID=34322007

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB031267971A Expired - Fee Related CN1269520C (en) 2003-06-05 2003-06-05 Medicine for treating human lithic disease

Country Status (1)

Country Link
CN (1) CN1269520C (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101199818B (en) * 2007-06-28 2010-06-02 周平 Medicament compound for treating calculus
CN101496893B (en) * 2009-03-06 2012-06-06 陈秀俊 Chinese medicinal composition for treating gall stone symptom and preparation method thereof
CN102600425B (en) * 2012-03-09 2014-03-26 龙步明 Chinese herba preparation with function of breaking stones and preparation method of Chinese herba preparation

Also Published As

Publication number Publication date
CN1552386A (en) 2004-12-08

Similar Documents

Publication Publication Date Title
CN101732621A (en) Chinese medicament for treating kidney stones
CN101279083B (en) Chinese medicine preparation for curing acute or chronic cholecystitis and method of preparing the same
CN104491052A (en) Traditional Chinese medicine composition for treating rheumatic and rheumatoid arthritis and preparation method thereof
CN102379996B (en) External Chinese medicament for treating scabies
CN101327305A (en) Chinese medicine for treating appendicitis and preparation method thereof
CN1269520C (en) Medicine for treating human lithic disease
CN1060391C (en) Traditional Chinese medicine for treating gynecological tumour
CN103211886A (en) Medicament for treating rheumatic arthritis
CN100579544C (en) Chinese medicament preparation for treating cholecystitis and gall-stone as well as preparation method thereof
CN101406643A (en) Chinese medicine micro powder granule for treating appendicitis
CN1049586C (en) Dressing medicine for treating hyperosteogeny and the prepn. method
CN1186044C (en) Chinese medicine 'lidandishi' for treating hepatobiliary calculus and cholecystitis
CN1084630C (en) Mastopathy treating ointment
CN102008635A (en) Traditional Chinese medicine preparation for treating acute pancreatitis
CN102552604A (en) Medicament for treating prostatitis and prostatic hyperplasia
CN101647880A (en) Medicament for treating appendicitis and preparation method thereof
CN1160102C (en) Chinese medicine for curing female chronic inflammation
CN101664459A (en) Hemorrhoid neixiaodan
CN1181879C (en) Analgestic plaster
CN103611078A (en) Oral traditional Chinese medicine liquid for treating chronic pelvic inflammation and preparation method thereof
CN1175875C (en) Medicine made of lysimachia for treating hepatobiliary calculus and its prescription
CN101810709A (en) Medicament for treating rheumatism
CN108295154A (en) A kind of drug and preparation process for treating kidney and lithangiuria
CN1277559C (en) Medicine for treating rheumatism and its preparation
CN1943669A (en) The Chinese traditional medicinal preparation for treatment of calculus

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060816

Termination date: 20110605